Hangzhou Pediatric High-End Preparation Research Institute （The first in China）
Joint Research Center for Intelligent Development of Improved New Drugs (Leadingpharm - Peking University Third Hospital)
Spearheaded clinical research in the fields of medical beauty, special medical food, cell and gene therapy drugs
Set up postdoctoral research workstation
Leadingpharm-Agilent Innovation Research (Beijing) Lab completed

Chongqing High-end Pharmaceutical Research Institute was completed
Pioneered an "interactive" clinical service model
The Analytical Testing center has passed CNAS certification

Built Leadingpharm CXO whole industry chain service
CDMO Base and Zhengzhou Pharmaceutical R&D Institute were established
Set Six high-end formulation drug delivery platforms(Zhongguancun Science Park High-precision Industry Collaborative Innovation Platform Project)

Established Miyun High-end API R&D Base
Established joint laboratories with Shimadzu China and Thermo Fisher
Quality System Construction (ISO9001 Certification)
Intellectual Property Management System Certification (Pilot Unit)
Beijing Municipal Enterprise Science and Technology Research and Development Institution

Establish Consistency Evaluation Center
Internal And External Bridging Center （The first in China） (Zhongguancun Science Park Innovation Platform Project)
Won the "Top Three Chinese Pharmaceutical R & D Companies"

Listed on the Shanghai Stock Exchange (stock code 600222)

Deep Blue Ocean Bio-Pharmaceutical Science and Technology Co, Ltd founded (Provide comprehensive clinical research services)

Incorporation
Corporate vision: We make China a world-class player in pharmaceutical technology development and production process!
Core values: loyalty, Thinking, Construction, Commitment, Sharing